Evid Invest
Holders — by stockHoldings — by fund

General Catalyst Group Management, LLC

Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-09-30 · filed with the SEC up to 45 days after quarter end · CIK 0001637946

$478.2M

disclosed book value

13

positions

60.9%

largest position share

Positions, as of 2026-09-30

top 13 of 13 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held

#IssuerSharesValue% of book
1QCOMQUALCOMM INC1.6M$291.4M60.9%
2PBLSPARABILIS MEDICINES INC1.6M$51.7M10.8%
3AVBPARRIVENT BIOPHARMA INC1.5M$45.3M9.5%
4CARTMAPLEBEAR INC710,711$30.6M6.4%
5MAZEMAZE THERAPEUTICS INC1.0M$28.2M5.9%
6ODTXODYSSEY THERAPEUTICS INC810,272$18.0M3.8%
7OSCROSCAR HEALTH INC299,923$9.2M1.9%
8CPNGCOUPANG INC79,177$1.1M0.2%
9METAMETA PLATFORMS INC1,320$957,2380.2%
10AMZNAMAZON COM INC3,532$879,9980.2%
11CVNACARVANA CO8,765$548,1630.1%
12DASHDOORDASH INC1,300$238,6150%
13MLMMARTIN MARIETTA MATLS INC175$83,9670%

Source: SEC Form 13F-HR, reporting period 2026-09-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.